We deliver 10 most active molecules (nutraceutical or pharmaceutical candidates) discovered via HTS.
hTERT or Follistatin AAV constructs (can be developed offshore).
Full HTS campaign (100k compounds)
Nutraceutical-only screen (20k library)
Custom AAV design and more
Why BioVoyager is a
High-Potential Opportunity
BioVoyager is a Tampa, Florida-based preclinical biotech company specializing in high-throughput screening (HTS) using GFP promoter-reporter assays and AAV gene therapy development for longevity pathways.
We focus on the most critical “shortest fuses” of aging: hTERT (telomerase), follistatin/myostatin, JAM2 (leaky gut), plus IL-17A, GSK3, 15-lipoxygenase, MC1R, and others.
Our business model is simple and capital-efficient:
We discover and validate — partners manufacture, regulate, and sell.
Revenue streams:
5–10% royalties on net sales
Custom CRO / HTS services
- Upfront licensing & research fees
- 5–10% royalties on net sales
- Custom CRO / HTS services
Investment Opportunity
Round size: $2,000,000
Minimum investment: $50,000
Use of funds:
- Expand compound library to 500,000
- Increase HTS capacity to 200k compounds/month
- Purchase additional equipment
- Hire 2 lab technicians
- Accelerate AAV construct development
Projected milestones with funding:
- First licensing deals in 2027
- First royalty revenue late 2027 / early 2028
- Move into Moffitt/Speros campus collaboration by 2028
Partnership Models
Multiple Ways to Collaborate
- + 5% royalty on net sales
- We deliver 10 most active molecules (nutraceutical or pharmaceutical candidates) discovered via HTS.
- Delivery: 6 months
- + technology transfer
- + 5% royalty
- hTERT or Follistatin AAV constructs (can be developed offshore).
- Timeline: 12 months
- Includes lab build-out and staff training at your facility.
- Full HTS campaign (100k compounds) — $150k
- Nutraceutical-only screen (20k library) — $40k
- Custom AAV design and more
- All terms are negotiable based on volume, exclusivity, and partner needs.
Get in Touch With Us.
Head Office
Tampa
Florida, US
Call Now
312-730-2562
786-307-1256
Email Us
dr.nikolic@ufl.edu
Why Partners Choose BioVoyager
Multi-target platform vs single-target competitors
Extremely cost-efficient (self-financed runway through 2029)
Direct access to USF labs + planned Moffitt expansion
Strong complementary team (molecular biology + data science + toxicology + neurosurgery)
Partner-first philosophy — we don’t want to build sales teams